Hypnotics use in children 0-18 months: moderate agreement between mother-reported survey data and prescription

Ingvild Holdø1, Jørgen G Bramness2, Marte Handal3

  • 1Norwegian Centre of Addiction Research (SERAF), University of Oslo, Oslo, Norway.

Insights

Mother-reported hypnotic use in young children showed less than 50% agreement with prescription records. This highlights data collection challenges in pediatric pharmacoepidemiology research.

Area of Science:

  • Pharmacoepidemiology
  • Pediatric drug utilization studies

Background:

  • Assessing hypnotic drug use in children (0-18 months) presents challenges as neither questionnaires nor prescription records are definitive.
  • This study compares the agreement between mother-reported data and prescription records for hypnotics versus antiepileptic drugs.

Purpose of the Study:

  • To investigate the agreement between mother-reported and prescription record data for hypnotic drug use in young children.
  • To compare this agreement with that of antiepileptic drugs.
  • To explore sociodemographic factors influencing data discrepancies.

Main Methods:

  • Utilized Norwegian prescription database and mother and child cohort data (2005-2009) for 47,413 children.
  • Calculated agreement using Cohens Kappa and analyzed discrepancies with multinomial logistic regression.

Main Results:

  • Agreement for hypnotics was under 50%, while for antiepileptic drugs it was 92.9%.
  • Reporting sensitivity for hypnotics improved with the number of filled prescriptions.
  • Paternal education and maternal work status were linked to data discrepancies.

Conclusions:

  • Moderate agreement exists between reported and dispensed hypnotic drugs in infants and toddlers.
  • Sociodemographic factors have a limited role in explaining the observed discrepancies in drug use data.
Abstract

Related Concept Videos

Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
682
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.7K
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
1.2K
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
468
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
1.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
371